Inspirna Overview
- Founded
- 2010

- Status
- Private
- Employees
- 21

- Latest Deal Type
- Series C
- Latest Deal Amount
- $6M

- Investors
- 17
Inspirna General Information
Description
Developer of novel cancer drugs intended to target key pathways in cancer progression. The company's drugs identify novel cancer targets that drive tumor growth and cancer progression using a microRNA-based target discovery platform and treats it via an oral small molecule cancer metabolism inhibitor, enabling cancer patients to get optimal cure using drugs that target using small molecules and antibodies.
Contact Information
- 310 East 67th Street
- Suite 1-12
- New York, NY 10065
- United States
Inspirna Timeline
Inspirna Valuation & Funding
Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
---|---|---|---|---|---|---|
6. Later Stage VC (Series C) | 24-Feb-2021 | $6M | 000.00 | 00000 | Completed | Clinical Trials - Phase 2 |
5. Later Stage VC (Series C) | 09-Oct-2018 | 0000 | 000.00 | 00000 | Completed | Clinical Trials - Phase 1 |
4. Later Stage VC | 03-Jun-2016 | 0000 | 000.00 | 0000 | Completed | Pre-Clinical Trials |
3. Early Stage VC (Series A) | 31-Jul-2015 | 000 | 000.00 | 0000 | Completed | Pre-Clinical Trials |
2. Grant | 11-Aug-2014 | $200K | $2.5M | Completed | Pre-Clinical Trials | |
1. Seed Round | 30-Sep-2013 | $2.5M | $2.5M | 00.00 | Completed | Pre-Clinical Trials |
Inspirna Cap Table
Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
---|---|---|---|---|---|---|---|---|
Series C | 00,000,000 | 00.000000 | 00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
Series B | 00,000,000 | 00.000000 | 00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
Series A | 13,889,841 | $0.000100 | $0.61 | $0.61 | 1x | $0.61 | 6.9% | |
Seed | 5,869,618 | $0.000100 | $0.53 | $0.53 | 1x | $0.53 | 2.92% |
Inspirna Comparisons
Industry
000000
00000000
PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.
Request a free trialInspirna Competitors (27)
Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
---|---|---|---|---|---|---|
Lycera | Venture Capital-Backed | Ann Arbor, MI | 00 | 00000 | 000000 - 000 | 00000 |
000000000 | Formerly VC-backed | Gaithersburg, MD | 00 | 00000 | 00000000 | 00000 |
000000 00000000000 | Formerly VC-backed | Burlingame, CA | 00 | 00000 | 000000 - 000 | 00000 |
00000000 000000000 | Formerly VC-backed | San Diego, CA | 000 | 00000 | 000000000 - | 00000 |
00000 000000000000 | Formerly VC-backed | Waltham, MA | 000 | 00000 | 00000000 | 00000 |
Inspirna Patents
Inspirna Recent Patent Activity
Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
---|---|---|---|---|---|
US-11174220-B2 | Metal salts and uses thereof | Active | 13-Dec-2019 | 0000000000 | 000 |
US-20210179539-A1 | Metal salts and uses thereof | Granted | 13-Dec-2019 | 000000000 | |
US-20210177790-A1 | Methods of treating cancer | Pending | 11-Dec-2019 | 0000000000 | |
CA-3130303-A1 | High-affinity anti-mertk antibodies and uses thereof | Pending | 26-Feb-2019 | 000000000 | |
US-20200291135-A1 | High-affinity anti-mertk antibodies and uses thereof | Pending | 26-Feb-2019 | C07K16/40 |
Inspirna Executive Team (17)
Inspirna Board Members (13)
Name | Representing | Role | Since |
---|---|---|---|
Antoine Papiernik | Sofinnova Partners | Board Member | 000 0000 |
David Darst | Self | Chief Operating Officer & Board Observer | 000 0000 |
Dieter Weinand | Inspirna | Chairman | 000 0000 |
Eric Rowinsky MD | Self | Board Member & Executive Chairman | 000 0000 |
Jue Pu | Inspirna | Board Member | 000 0000 |
Inspirna Signals
Growth Rate

Growth

Size Multiple


Key Data Points
Twitter Followers
5.5k

Similarweb Unique Visitors
15.0K

Majestic Referring Domains
314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.
Request a free trialInspirna Investors (17)
Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
---|---|---|---|---|---|
Bolur Holdings | Impact Investing | Minority | 000 0000 | 000000 0 | |
EXOR Seeds | Venture Capital | Minority | 000 0000 | 000000 0 | |
Lepu Medical | Corporation | Minority | 000 0000 | 000000 0 | |
Oceanpine Capital | Venture Capital | Minority | 000 0000 | 000000 0 | |
Oceanpine Healthcare Fund | Venture Capital | Minority | 000 0000 | 000000 0 |